Recruiting nowPhase 1
A Study to Evaluate ALN-6222 in Participants With Obesity
Updated 2026-09-03 · NCT07624071See eligibility →
Sponsor
Clinical trials sponsored by Alnylam Pharmaceuticals
Active studies whose public registry record names Alnylam Pharmaceuticals as lead sponsor.
3active studies
2recruiting now
6countries represented
22largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 1, Phase 2
A Study to Evaluate ALN-2232 in Participants With Obesity
Updated 2026-08-12 · NCT07463846See eligibility →
Active, not recruitingPhase 1, Phase 2
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
Updated 2026-08-14 · NCT06845202See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.